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 Abstract 
 
The monodentate phosphine complexes bui3PMX (2a: M = Cu, X = Cl, 2b: M = Cu, X = 
I, 2c: M = Ag, X = Cl, 2d: M = Au, X = Cl) were synthesised in high yields from bui3P 
and MX. Their reaction with [Li{µ-N(R)C(but)C(H)R}]2 (R = SiMe3) gave the 
monomeric complexes bui3PCuN(R)C(but)=C(H)R (3a) and bui3PMC(H)RC(but)=NR 
(3b: M = Ag, 3c: M = Au) in moderate to high yields. The bonding mode in the 1-aza-
allyl complexes 3a-c was found to depend strongly on the metal ion, with 3a being an 
enamide complex and 3b and 3c iminoalkyl complexes.  
 
The reaction of bidentate ligand dpmaaH2 (2,3-bis(diphenylphosphino)maleic acid) with 
R2Sn-precursors led to novel dialkyl tin dpmaa complexes (R2Sn)(O,O dpmaa) (6) (where 
6a, R = Me; 6b, R = Bu) were synthesized.  
 
Complexation of the tin/phosphine complexes led to the heterobimetallic complexes 
{Au[(dpmaaO,O)(SnR2)]2}Cl (7a and 8a) {Au[(dpmaaO,O)(SnR2)][dpmaaH2]}Cl (7b 
and 8b) (where 7a and 8a, R = Me; 7b and 8b, R = Bu) and the mixed metal complexes 
{Au[(dpmaaO,O)(RuCl)]2}Cl (9a) {Au[(dpmaaO,O)(SnBu2)(dpmaaO,O)RuCl)]}Cl (9b) 
and  {Au[(dpmaaO,O)(RuCl)][dpmaa]}Cl (9c).  
 
All compounds were fully characterised by multinuclear NMR spectroscopy and 
microanalysis (not 3a, 3b, 4 and 5) solid state IR spectroscopy (KBr-pellets) (4-9) and 
mass spectrometry (6-8). The solid state structures of complexes 2c, 2d, 3c, 6a and 6b 
(two polymorphs) have been determined by X-ray crystallography revealing the presence 
of rare trimeric macrocycles in the case of 6a and 6b.  
 
The anti-tumour activity of the metal complexes (6b and 7-9) was tested on a single cell-
line (except 7a and 8a which were on eight cell-lines) and their activity was compared to 
cisplatin. 
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